Dr Caroline Pilot
Chief Health Officer
Caroline is an expert in the design and delivery of digital healthcare products and services both in the UK and on an international stage. She is a specialist in using algorithmic intelligence to augment and assist consultations. She has sat on the Digital Health Cabinet at the invitation of the UK government and was awarded Honorary Professor of Algorithmic Medicine in recognition of her contribution to the field. She also remains a practising NHS GP.
Barnaby Poulton
Chief Executive Officer
As Chief Executive Officer, Barnaby sets Vitomics' strategy and leads the business as it brings laboratory metabolomics to the wellness market. He brings commercial leadership and business acumen built across 30 years in healthcare. He began his career in the NHS as a pharmacist and has worked in the pharmaceutical industry in both commercial and R&D in UK, European and global roles. He has co-founded or built numerous medical technology companies in sectors as diverse as digital clinical service provision to genomic sequencing and regularly coaches and mentors company founders and start ups.
Chief Scientific Officer
Science & Laboratory
Our Chief Scientific Officer leads the science behind Vitomics. They hold a PhD in biochemistry, with research focused on innovative approaches to biofluid analysis and their use in detecting meaningful metabolic changes. They have authored peer-reviewed research and continue to advance the field through collaborations with academic institutions. At Vitomics, they oversee our laboratory, analytical methods and data quality, so that every result we report is backed by robust, validated science.
Professor Rishabh Prasad
Founder & Director · MBBS FRCGP SFFMLM FBCS FRSA
Rishabh founded Vitomics to make metabolomic insight into everyday health accessible, understandable and trustworthy. A practising GP and Chair of Willows Health, a 12-site NHS primary care group serving around 65,000 patients across Leicestershire, he brings scientific rigour to a consumer health proposition. As Honorary Professor of Medical Technology at De Montfort University, formerly at Nottingham Trent University, he evaluates emerging technologies for their evidence base and real-world value, the same test he applies to Vitomics. In the pandemic he founded Crown Labs, delivering PCR testing and genomic sequencing to exacting quality standards.
Daniel Coleman
Chair
Daniel chairs the Vitomics board, guiding governance, investor relations and funding strategy as the company brings simple, non-invasive urine testing to everyday health. A veteran City executive with 37 years in asset management, he brings sound judgement and disciplined stewardship of capital. As a Director at Hargreave Hale Wealth Management, he helped lead a business managing £8 billion in assets, and he spent four years as an Investment Director at Canaccord Genuity. He now supports purpose-led, growth-stage businesses including Blackbullion and Milliways, and previously guided Genetix, a mould reporting business, through to a successful exit, delivering a substantial return for investors.